Bliss GVS Pharma Ltd. - Research Center
506197 BLISSGVS Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
280.31 |
286.13 |
328.90 |
307.46 |
232.84 |
Operating profit |
53.36 |
45.78 |
50.50 |
58.70 |
44.98 |
Interest |
2.49 |
3.88 |
2.49 |
1.84 |
1.55 |
Gross profit |
68.01 |
74.77 |
66.76 |
70.74 |
53.56 |
EPS (Rs) |
3.96 |
4.82 |
4.46 |
4.48 |
3.48 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
17.14 |
32.86 |
18.75 |
13.88 |
10.13 |
Stock adjustment |
-12.49 |
6.88 |
9.84 |
-18.74 |
-3.12 |
Raw material |
146.73 |
148.02 |
170.34 |
180.49 |
94.95 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
40.74 |
35.34 |
33.26 |
31.79 |
27.77 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
51.97 |
50.10 |
64.95 |
55.22 |
68.27 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
11.04 |
7.41 |
6.92 |
6.93 |
6.88 |
Taxation |
15.58 |
17.27 |
16.31 |
17.43 |
10.79 |
Net profit / loss |
41.39 |
50.09 |
46.28 |
46.39 |
35.88 |
Extra ordinary item |
- |
- |
2.75 |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.44 |
10.39 |
10.37 |
10.35 |
10.31 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
19.04 |
16.00 |
15.36 |
19.09 |
19.32 |
GPM (%) |
22.87 |
23.44 |
19.20 |
22.01 |
22.04 |
NPM (%) |
13.91 |
15.70 |
13.31 |
14.43 |
14.77 |